Cencora, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cencora, Inc. on November 9, 2023. The filing discloses the entry into a Material Definitive Agreement regarding a share repurchase transaction with a significant stockholder.
Key Financial Metrics and Transaction Details
- Transaction Type: Share Repurchase Agreement.
- Counterparty: Walgreens Boots Alliance Holdings LLC (Selling Stockholder).
- Shares Repurchased: 1,279,590 shares of Common Stock.
- Total Consideration: Approximately $250 million.
- Expected Closing Date: November 14, 2023.
- Post-Transaction Ownership: The Selling Stockholder will retain approximately 30,489,956 shares, representing approximately 15% of the total outstanding shares.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this report focuses on a specific corporate action rather than periodic financial results.
Material Changes and Context
The repurchase is being executed under the Company's existing share repurchase program. The transaction is connected to the Selling Stockholder entering into variable pre-paid forward sale contracts with financial institutions, executed in reliance on Rule 144 of the Securities Act of 1933. The repurchased shares will be held in treasury.
Guidance, Risks, and Unusual Items
The filing does not contain updated financial guidance, management commentary on operational outlook, or new risk factors beyond the standard disclosure of the transaction mechanics. The transaction is a routine execution of a share repurchase program involving a major shareholder.
Key Facts for Investor Verification
- Verify the final closing date of the $250 million repurchase (expected November 14, 2023).
- Confirm the updated total share count and the Selling Stockholder's exact percentage ownership post-closing.
- Review the full text of the Share Repurchase Agreement (Exhibit 10.1) for specific terms and conditions.
- Monitor subsequent filings for the impact of this transaction on the Company's cash position and treasury stock balance.